Parin5, a novel thrombin receptor antagonist modulates a streptozotocin mice model for diabetic encephalopathy

HIGHLIGHTS

• who: Valery Golderman and colleagues from the Department of Neurology, The Chaim Sheba Medical Center, Department of Neurology and Neurosurgery, Sackler Faculty of Medicine, University have published the Article: PARIN5, a Novel Thrombin Receptor Antagonist Modulates a Streptozotocin Mice Model for Diabetic Encephalopathy, in the Journal: (JOURNAL)
• what: The authors report behavioral changes in STZ diabetic mice, accompanied by the elevation of serum NfL levels as a highly sensitive marker for neuronal damage. The authors report a significant elevation in serum NfL, a subtle behavioral and cognitive deficit, an increased CNS intrinsic expression of coagulation . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.